Recent Articles

From data to decisions: Big data and AI are shaping the future of radiotherapy and individualized treatment of nasopharyngeal carcinoma

January 2025

Zicheng Zhen | Yuxian Yang | Chenyang Feng | Li Lin | Jun Ma | Ying Sun

Multi-omics synergy in oncology: Unraveling the complex interplay of radiomic, genoproteomic, and pathological data

January 2025

Yang Luo | Yilin Li | Mengjie Fang | Shuo Wang | Lizhi Shao | Ruiyang Zou | Di Dong | Zhenyu Liu | Jingwei Wei | Jie Tian

The advent of multi-omics approaches has revolutionized the field of oncology by enabling a comprehensive understanding of cancer biology through the integration of diverse biological data. This review...

Redefining the future of cancer care: Intelligent Oncology unveiled

January 2025

Bo Xu

Artificial intelligence in clinical trials of lung cancer: Current and future prospects

January 2025

Yuhang Zhang | Peimeng You | Ruizhe Liu | Yingwei Lu | Jinqing Li | Yu Lei | Shaowei Wu | Haiyu Zhou

Lung cancer remains a leading cause of mortality globally, with particularly high incidence rates in China. This review investigates the pivotal role of artificial intelligence (AI) in the clinical...

Development and validation of AI delineation of the thoracic RTOG organs at risk with deep learning on multi-institutional datasets

January 2025

Xianghua Ye | Dazhou Guo | Lujun Zhao | Congying Xie | Dandan Zheng | Haihua Yang | Xiangzhi Zhu | Xin Sun | Pingping Dong | Huanhuan Li | Weiwei Kong | Jianzhong Cao | Honglei Chen | Juntao Ran | Kai Ren | Hongxin Su | Hao Hu | Cuimeng Tian | Tianlu Wang | Qiang Zeng | Xiao Hu | Ping Peng | Junhua Zhang | Li Zhang | Tingting Zhang | Lue Zhou | Wenchao Guo | Zhanghexuan Ji | Puyang Wang | Hua Zhang | Jiali Liu | Le Lu | Senxiang Yan | Dakai Jin | Feng-Ming (Spring) Kong

Accurate contouring of thoracic organs at risk (OARs) is essential for minimizing complications in radiation treatment. Manual contouring of thoracic OARs is not only time-consuming but also prone to...

Discovery of novel EGFR and BRAF inhibitors by machine learning approach

January 2025

Hailong Zhang | Henry H.Y. Tong

In the pharmaceutical industry, epidermal growth factor receptor (EGFR) and B-Raf proto-oncogene, serine/threonine kinase (BRAF) are the primary targets for targeted cancer therapy....